Discover 3,059 paid clinical trials in Cambridge, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,059
BILe Acid-gut Microbiome Axis MODification Through Diet Education for Colorectal Cancer Prevention
for
Colorectal Cancer Prevention, Colorectal Adenoma
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18 - 70+
Code: NCT07162337
Recruiting
A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
for
KRAS-mutant Non-small Cell Lung Cancer (NSCLC),
Location: Boston MA, Philadelphia PA, Fairfax VA, Tampa FL,
Sponsor: Kestrel Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07458347
Phase 1, Recruiting
Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors
for
Colorectal Cancer Prevention, Colorectal Adenoma
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18 - 50
Code: NCT07095517
Phase 1, Recruiting
DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma
for
Refractory Melanoma
Location: Boston MA, Morristown NJ, Chapel Hill NC, Birmingham AL,
Sponsor: Diakonos Oncology Corporation
Sex: All
Age: 18+
Code: NCT07288112
Phase 1, Phase 2, Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Boston MA, Lebanon NH, Commack NY, Harrison NY,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT07097142
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
for
Advanced Hepatocellular Carcinoma,
Location: Boston MA, Waterford CT, Glastonbury CT, Hartford CT,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT07166406
Phase 3, Recruiting
Adapting Psychosocial Resiliency Intervention for Parents of Adolescents and Young Adults With Cancer
for
Caregiving for Cancer
Location: Boston MA
Sponsor: Zeba Ahmad, Ph.D.
Sex: All
Age: 18+
Code: NCT07139769
Recruiting
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
for
Advanced Solid Tumors, Ewing Sarcoma,
Location: Boston MA, New York NY, Houston TX, Duarte CA,
Sponsor: SEED Therapeutics, Inc.
Sex: All
Age: 16+
Code: NCT07197554
Phase 1, Recruiting
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
for
Head and Neck Squamous Cell Carcinoma HNSCC,
Location: Boston MA, New York NY, Washington D.C. DC, Fairfax VA,
Sponsor: Sutro Biopharma, Inc.
Sex: All
Age: 18+
Code: NCT07227168
Phase 1, Recruiting
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Location: Boston MA, Providence RI, Hartford CT, Scarborough ME,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 30
Code: NCT03126916
Phase 3, Recruiting
RESOLVE: Abemaciclib + Letrozole +/- Metformin or Gedatolisib in Endometrial Cancer
for
Endometrial Cancer
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute
Sex: Female
Age: 18+
Code: NCT03675893
Phase 2, Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
for
Breast Neoplasms, Triple Negative Breast Neoplasms,
Location: Boston MA, Westbrook ME, Hackensack NJ, Sherbrooke,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06966700
Phase 3, Recruiting
Supportive Psychoeducational Intervention for Patients With Brain Tumors (Acceptance and Commitment Therapy-based Supportive Intervention for Patients With Central Nervous System Tumors)
for
Malignant Brain Tumor, Glioma, Coping Skills,
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT06099743
Recruiting
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
for
cGVHD
Location: Boston MA, New York NY, New Brunswick NJ, Danville PA,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT05919511
Recruiting
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations